21 Jun 2007 - Basingstoke, U.K., and Philadelphia, U.S. – June 21, 2007 -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that it has received an approvable letter from the U.S. Food ...
Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17 INTUNIV, the first nonscheduled alpha-2A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results